0001726243-19-000001.txt : 20190627
0001726243-19-000001.hdr.sgml : 20190627
20190627170209
ACCESSION NUMBER: 0001726243-19-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20190627
DATE AS OF CHANGE: 20190627
EFFECTIVENESS DATE: 20190627
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRS & Co. IV, L.P.
CENTRAL INDEX KEY: 0001726243
IRS NUMBER: 473230794
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-301543
FILM NUMBER: 19926153
BUSINESS ADDRESS:
STREET 1: 126 EAST 56TH STREET, 29TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-521-3700
MAIL ADDRESS:
STREET 1: 126 EAST 56TH STREET, 29TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001726243
BRS & Co. IV, L.P.
c/o Bruckmann, Rosser, Sherrill & Co.
126 EAST 56TH STREET, 29TH FLOOR
NEW YORK
NY
NEW YORK
10022
212-521-3700
DELAWARE
Bruckmann, Rosser, Sherrill & Co, IV, L.P.
None
Limited Partnership
true
2015
Stephen
C.
Sherrill
c/o Bruckmann, Rosser, Sherrill & Co.
126 East 56th Street, 29th Floor
New York
NY
NEW YORK
10022
Director
Managing Director of the GP of the GP of the Issuer
Bruce
C.
Bruckmann
c/o Bruckmann, Rosser, Sherrill & Co.
126 East 56th Street, 29th Floor
New York
NY
NEW YORK
10022
Director
Managing Director of the GP of the GP of the Issuer
Thomas
J.
Baldwin
c/o Bruckmann, Rosser, Sherrill & Co.
126 East 56th Street, 29th Floor
New York
NY
NEW YORK
10022
Director
Managing Director of the GP of the GP of the Issuer
Pooled Investment Fund
Private Equity Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
true
0001726243-17-000001
2017-12-22
true
true
true
false
0
250000000
139705000
110295000
The General Partner reserves the right to offer a greater or lesser amount of limited partner interests.
false
29
0
0
0
true
The general partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials.
false
BRS & Co. IV, L.P.
Stephen C. Sherrill
Stephen C. Sherrill
Managing Director of the GP of the GP of the Issuer
2019-06-26